Habits: Clinical Trials

6 trials for Habits, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 2, Recruiting 2, Terminated 1, Unknown 1

Follow Habits: new trials by email Literature Review of Habits trials Research Report on Habits

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism
Botulinum Toxin Type A 100U, Ibuprofen - Bruxism, Myofascial Pain
Phase 4CompletedCyprus Health and Social Sciences University402026-02-062026-07-29
EMG-Based Evaluation of Occlusal Splint and Masseter Botox Effects on Head and Neck Muscles
Botulinum toxin injection, Occlusal splint, Botulinum toxin + Occlusal splint combined - Myofascial Pain Syndrome (MPS), Masticatory Muscle Pain
Phase 4RecruitingIstanbul University562025-09-012025-07-24
Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism Pain
Chlorzoxazone, Orphenadrine Citrate - Orofacial Pain, Bruxism
Phase 4RecruitingUniversity of Baghdad602025-07-222025-08-07
Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism
Botulinum toxin type A (Meditoxin®) - Sleep Bruxism
Phase 4UnknownYonsei University242011-03-012011-04-19
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
lidocaine, chemodenervation - Face Pain
Phase 4TerminatedUniversity of California, Los Angeles172009-10-012016-12-29
Study of the Safety and Efficacy of Botox in Bruxism
Botulinum toxin type A, Placebo arm - Bruxism
Phase 4CompletedBaylor College of Medicine232009-04-012023-06-18

Narrower conditions

Bruxism (6)  ·  Facial Pain (2)  ·  Myofascial Pain Syndromes (1)  ·  Sleep Bruxism (1)

Broader conditions

Behavior (6)  ·  Stomatognathic Diseases (6)  ·  Tooth Diseases (6)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Mental Disorders (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Parasomnias (1)  ·  Sleep Wake Disorders (1)

Interventions

Botulinum Toxins, Type A (3)  ·  Botulinum Toxins (1)  ·  Chlorzoxazone (1)  ·  Ibuprofen (1)  ·  Lidocaine (1)  ·  Nerve Block (1)  ·  Occlusal Splints (1)  ·  Orphenadrine (1)

Sponsors

Baylor College of Medicine (1)  ·  Cyprus Health and Social Sciences University (1)  ·  Istanbul University (1)  ·  University of Baghdad (1)  ·  University of California, Los Angeles (1)  ·  Yonsei University (1)

Countries

United States (2)  ·  Cyprus (1)  ·  Iraq (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Marisa Chang, M.D. (1)  ·  SeongTaek Kim, PhD (1)  ·  William G Ondo, MD (1)

Results publications

PMID 19492540, PMID 33061557, PMID 39064299